Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

Extended-release mesalamine granules for ulcerative colitis.

Love BL, Miller AD.

Ann Pharmacother. 2012 Nov;46(11):1529-36. doi: 10.1345/aph.1R171. Epub 2012 Oct 31. Review.

PMID:
23115226
2.

Aminosalicylates for induction of remission or response in Crohn's disease.

Lim WC, Hanauer S.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD008870. doi: 10.1002/14651858.CD008870. Review.

PMID:
21154400
3.

[Effectiveness of new, once-daily 5-aminosalicylic acid in the treatment of ulcerative colitis].

Lakatos PL, Lakatos L.

Orv Hetil. 2009 Mar 1;150(9):397-404. doi: 10.1556/OH.2009.28555. Review. Hungarian.

4.

Once daily 5-aminosalicylic acid for the treatment of ulcerative colitis; are we there yet?

Lakatos PL, Lakatos L.

Pharmacol Res. 2008 Sep-Oct;58(3-4):190-5. doi: 10.1016/j.phrs.2008.08.003. Epub 2008 Aug 28. Review.

PMID:
18801439
5.

A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis.

Nikfar S, Rahimi R, Rezaie A, Abdollahi M.

Dig Dis Sci. 2009 Jun;54(6):1157-70. doi: 10.1007/s10620-008-0481-x. Epub 2008 Sep 4. Review.

PMID:
18770034
6.

Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis.

Rahimi R, Nikfar S, Rezaie A, Abdollahi M.

Reprod Toxicol. 2008 Feb;25(2):271-5. doi: 10.1016/j.reprotox.2007.11.010. Epub 2007 Dec 4.

PMID:
18242053
7.

Multi-matrix system mesalamine: to use or not to use.

Kale-Pradhan PB, Pradhan RS, Wilhelm SM.

Ann Pharmacother. 2008 Feb;42(2):265-9. doi: 10.1345/aph.1K469. Epub 2008 Jan 8. Review.

PMID:
18182473
8.

Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis.

Loftus EV Jr, Kane SV, Bjorkman D.

Aliment Pharmacol Ther. 2004 Jan 15;19(2):179-89. Review.

9.

The efficacy of oral 5-ASAs in the treatment of active ulcerative colitis: a systematic review.

Kane SV, Bjorkman DJ.

Rev Gastroenterol Disord. 2003 Fall;3(4):210-8. Review.

PMID:
14668693
11.

Olsalazine was not better than placebo in maintaining remission in inactive Crohn disease.

Luthra G, Pasricha PJ.

ACP J Club. 2002 May-Jun;136(3):92. No abstract available.

PMID:
11985433
12.

Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis.

Kornbluth AA, Salomon P, Sacks HS, Mitty R, Janowitz HD.

J Clin Gastroenterol. 1993 Apr;16(3):215-8.

PMID:
8099363
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk